Skip to main content
Help
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Lockups
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
Analysts
News
Trending
Private Companies
Technical Chart
Fundamental Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Bausch + Lomb Corporation (TSX:BLCO)
Canada
· Delayed Price · Currency is CAD
Full Chart
Watchlist
Alerts
Compare
23.53
+0.04 (0.17%)
Sep 18, 2026, 3:59 PM EST
Overview
Financials
Statistics
History
Profile
Primary
Chart
Financials
Income Statement
Balance Sheet
Cash Flow
Ratios
Annual
Quarterly
TTM
Bausch + Lomb Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Revenue & Profits
TTM
Annual
Indicators
USD
USD
Download
Full Width
5Y
10Y
Max
Chart
Revenue
Gross Profit
Operating Income
Net Income
EPS
Fiscal Year
TTM
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Revenue
Revenue Growth
5,324
5,101
4,791
4,146
3,768
3,765
Revenue Growth
8.85%
6.47%
15.56%
10.03%
0.08%
10.35%
Gross Profit
Gross Profit Growth
3,271
3,051
2,919
2,504
2,249
2,298
Operating Income
Operating Income Growth
405
188
206
204
220
347
Net Income
Net Income Growth
-171
-360
-317
-260
6
182
Earnings Per Share
EPS Growth
-0.48
-1.02
-0.90
-0.74
0.02
0.52
EPS Growth
-
-
-
-
-96.70%
-
Revenue by Segment
TTM
Annual
USD
USD
Download
Full Width
5Y
10Y
Max
Chart
Vision Care
Surgical
Ophthalmic Pharmaceuticals
Fiscal Year
TTM
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Vision Care
Vision Care Growth
3,009
2,923
2,739
2,543
2,369
2,343
Surgical
Surgical Growth
948
894
843
767
718
718
Ophthalmic Pharmaceuticals
Ophthalmic Pharmaceuticals Growth
1,367
1,284
1,209
836
681
704
Revenue (Total)
Revenue (Total) Growth
6,005
5,101
4,791
4,146
3,768
3,765
Cash & Debt
Current
Annual
Indicators
USD
USD
Download
Full Width
5Y
10Y
Max
Chart
Cash & Investments
Total Debt
Net Cash
Fiscal Year
Current
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Cash & Investments
Cash & Investments Growth
367
383
305
331
354
174
Total Debt
Total Debt Growth
5,115
5,245
4,936
4,676
2,528
140
Net Cash (Debt)
Net Cash Growth
-4,748
-4,862
-4,631
-4,345
-2,174
34
Net Cash Growth
-
-
-
-
-
-75.18%
Net Cash Per Share
Net Cash Per Share Growth
-13.37
-13.74
-13.16
-12.40
-6.21
0.10
Cash Flow & CapEx
TTM
Annual
Indicators
USD
USD
Download
Full Width
5Y
10Y
Max
Chart
Operating Cash Flow
CapEx
Free Cash Flow
Fiscal Year
TTM
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Operating Cash Flow
Operating Cash Flow Growth
458
283
232
-17
345
873
Capital Expenditures
CapEx Growth
-321
-349
-291
-181
-175
-193
Free Cash Flow
Free Cash Flow Growth
137
-66
-59
-198
170
680
Free Cash Flow Growth
-
-
-
-
-75.00%
152.79%
Margins
TTM
Annual
Indicators
USD
USD
Download
Full Width
5Y
10Y
Max
Chart
Gross Margin
Operating Margin
Pretax Margin
Profit Margin
FCF Margin
Fiscal Year
TTM
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Gross Margin
61.44%
59.81%
60.93%
60.40%
59.69%
61.04%
Operating Margin
7.61%
3.69%
4.30%
4.92%
5.84%
9.22%
Pretax Margin
-1.22%
-6.21%
-4.88%
-4.00%
1.94%
8.45%
Profit Margin
-3.21%
-7.06%
-6.62%
-6.27%
0.16%
4.83%
FCF Margin
2.57%
-1.29%
-1.23%
-4.78%
4.51%
18.06%
Valuation
Current
Annual
Indicators
USD
USD
Download
Full Width
5Y
10Y
Max
Chart
PE Ratio
P/FCF Ratio
PS Ratio
Fiscal Year
Current
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Period Ending
Sep '26
Sep 21, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
PE Ratio
-
-
-
-
904.75
-
P/FCF Ratio
43.33
-
-
-
31.93
-
PS Ratio
1.12
1.19
1.33
1.44
1.44
-
Back to Top ↑